Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Milton Louis Hoefle is active.

Publication


Featured researches published by Milton Louis Hoefle.


Archive | 1984

Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis

Milton Louis Hoefle; Bruce D. Roth; Charlotte D. Stratton


Archive | 1981

Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids

Milton Louis Hoefle; Sylvester Klutchko


Journal of Medicinal Chemistry | 1986

Synthesis of novel angiotensin converting enzyme inhibitor quinapril and related compounds. A divergence of structure-activity relationships for non-sulfhydryl and sulfhydryl types

Sylvester R. Klutchko; C. John Blankley; Robert W. Fleming; Jack M. Hinkley; Ann E. Werner; Ivan Nordin; Ann Holmes; Milton Louis Hoefle; David Cohen


Journal of Medicinal Chemistry | 1990

Inhibitors of cholesterol biosynthesis. 2. 1,3,5-trisubstituted [2-(tetrahydro-4-hydroxy-2-oxopyran-6-yl)ethyl]pyrazoles.

Drago R. Sliskovic; Bruce David Roth; Michael W. Wilson; Milton Louis Hoefle; Roger S. Newton


Journal of Medicinal Chemistry | 1975

Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.

Milton Louis Hoefle; S. Hastings; Robert F. Meyer; Ruth M. Corey; Ann Holmes; Charlotte D. Stratton


Journal of Medicinal Chemistry | 1990

Inhibitors of cholesterol biosynthesis. 1. trans-6-(2-pyrrol-1-ylethyl)-4-hydroxypyran-2-ones, a novel series of HMG-CoA reductase inhibitors. 1. Effects of structural modifications at the 2- and 5-positions of the pyrrole nucleus.

Bruce David Roth; Daniel F. Ortwine; Milton Louis Hoefle; Charlotte D. Stratton; Drago R. Sliskovic; Michael William Wilson; Roger S. Newton


Journal of the American Chemical Society | 1960

Pyrimido [4,5-d]pyrimidines. Part I

Edward C. Taylor; Robert J. Knopf; Robert F. Meyer; Ann Holmes; Milton Louis Hoefle


Journal of Medicinal Chemistry | 1987

Synthesis and structure-activity relationships of potent new angiotensin converting enzyme inhibitors containing saturated bicyclic amino acids.

C. J. Blankley; James Stanley Kaltenbronn; D. E. Dejohn; A. Werner; Lawrence Ray Bennett; G. Bobowski; U. Krolls; Don Johnson; W. M. Pearlman; Milton Louis Hoefle; Arnold D. Essenburg; David Cohen; Harvey R. Kaplan


Journal of Medicinal Chemistry | 1981

Novel synthesis of (S)-1-[5-(benzoylamino)-1,4-dioxo-6-phenylhexyl]-L-proline and analogues: potent angiotensin converting enzyme inhibitors.

Robert F. Meyer; Ernest. Nicolaides; Francis G. Tinney; Elizabeth A. Lunney; Ann Holmes; Milton Louis Hoefle; Ronald D. Smith; Arnold D. Essenburg; Harvey R. Kaplan; Ronald G. Almquist


Journal of Medicinal Chemistry | 1982

Derivatives of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline: effect of changes at positions 2 and 5 of the hexanoic acid portion.

Ronald G. Almquist; Jac Crase; Clive Jennings-White; Robert F. Meyer; Milton Louis Hoefle; Ronald D. Smith; Arnold D. Essenburg; Harvey R. Kaplan

Collaboration


Dive into the Milton Louis Hoefle's collaboration.

Researchain Logo
Decentralizing Knowledge